Hepatitis C 
The MD Magazine Hepatitis C condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Hepatitis C Treatment Panel Calls For Hepatitis B Testing
Hepatitis B and C are caused by different viruses that can start as acute infections but turn chronic in some people and eventually lead to life-threatening liver damage, according to the Centers for Disease Control and Prevention. While there are vaccines to prevent hepatitis A and B, there is no vaccine for hepatitis C.
Interferon treatment has long been a difficult regimen for patients with hepatitis C, but it is still used. A study found a thyroid concern.
Hepatocellular carcinoma, the cancer that can result from untreated HCV infection, can be caught earlier with MRIs than the current standard practice of monitoring with ultrasounds, a Korean team reports.
The World Health Organization (WHO) set a target to eliminate hepatitis C by 2030, and one of the ways that can become a reality is by identifying commonly infected populations. Prisons are one place where the virus thrives.
People living with HIV/AIDS may have trouble getting authorization for HCV direct acting antivirals. Amida Care in NYC, a Medicai MCO came up with a plan.
According to Charles King, President and CEO of Housing Works, "It really doesn't matter what part of the world you're in. If you're having to struggle with issues around sexism, racism, homophobia, transphobia, homelessness, addiction, mental illness, they are all drivers of very bad health outcomes for people - whether you're talking about HIV, hepatitis C, or tuberculosis."
A study of Scottish patients who had been treated and cured of hepatitis C found that the group had a higher mortality rate compared to the general population.
Researchers say they have found a new and potentially cheaper and better way to diagnose HCV.
The International Network for Hepatitis C in Substance Users points to economic and pseudo-scientific barriers that keep drug-using hepatitis sufferers from receiving new, effective treatments, including an assumption that illicit drug use reduced the efficacy of certain medications

Most Popular


$vacMongoViewPlus$ $vAR$